tokyo

Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease

In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…

2 months ago

Updated IOC report shows 86 per cent of all permanent Olympic venues still in use

23 October 2025 - An updated analysis of venues shows that 86 per cent of all permanent venues used at the…

2 months ago

Casio to Release Ring-Sized G-SHOCK

Shock-Resistant Structure and 200-Meter Water Resistance Packed in Smallest Size in Brand's History TOKYO, Oct. 20, 2025 /PRNewswire/ -- Casio…

2 months ago

ESR and Colt DCS Announce Joint Venture on New Osaka Data Centre Development

TOKYO, Oct. 16, 2025 /PRNewswire/ -- ESR, an Asia-Pacific ("APAC") focused real asset owner and manager, and Colt Data Centre…

2 months ago

Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases

Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional…

3 months ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

3 months ago

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China

September 28, 2025 19:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai…

3 months ago

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan

BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.  (NASDAQ: LNTH) and GE HealthCare…

3 months ago

Spider Labs Rebrands as Marketing Security Platform to Strengthen Digital Risk Protection

TOKYO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spider Labs Inc., provider of Spider AF, Japan’s No.1 ad fraud prevention tool…

3 months ago

Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs REMONY for Advanced Health Monitoring and Heatstroke Safety

TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM…

3 months ago